{"id":"NCT02569242","sponsor":"Ono Pharmaceutical Co. Ltd","briefTitle":"Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer","officialTitle":"ONO-4538 Phase III Study A Multicenter, Randomized, Open-label Study in Patients With Esophageal Cancer Refractory or Intolerant to Combination Therapy With Fluoropyrimidine and Platinum-based Drugs","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-14","primaryCompletion":"2020-10-23","completion":"2020-10-23","firstPosted":"2015-10-06","resultsPosted":"2022-01-14","lastUpdate":"2022-07-06"},"enrollment":419,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Esophageal Cancer"],"interventions":[{"type":"DRUG","name":"Nivolumab","otherNames":[]},{"type":"DRUG","name":"Docetaxel/Paclitaxel","otherNames":[]}],"arms":[{"label":"Nivolumab Arm","type":"EXPERIMENTAL"},{"label":"Active Comparator Arm （Docetaxel/Paclitaxel）","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of study is to evaluate the efficacy and safety of Nivolumab in unresectable advanced or recurrent esophageal cancer patients who have failed in standard chemotherapies.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"(\"Date of death from any cause\" - \"Date of randomization\" + 1) / 30.4375. For subjects lost to follow-up and subjects who are alive at the time of data cutoff date, data will be censored at the time the subject was last confirmed to be alive.","effectByArm":[{"arm":"Nivolumab Arm","deltaMin":10.9,"sd":null},{"arm":"Active Comparator Arm （Docetaxel/Paclitaxel）","deltaMin":8.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":89,"countries":["United States","Denmark","Germany","Italy","Japan","South Korea","Taiwan","United Kingdom"]},"refs":{"pmids":["31582355"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":68,"n":209},"commonTop":["Decreased appetite","Alopecia","Anaemia","Neutrophil count decreased","Constipation"]}}